Medhat Askar, MD, PhD, MSHPE, FRCPath, D(ABHI), D(ABMLI), HCLD(ABB), Professor of Pathology and Laboratory Medicine, Texas A&M College of Medicine, Director of Transplant Immunology and Assistant Hematopoietic Cell Processing Facility Laboratory Director at Baylor University Medical Center, Dallas, TX, USA. After completing his MD and PhD (Cairo, Egypt) he trained in transplant immunology at Thomas Starzl Transplantation Institute (Pittsburgh, PA). He is board certified by the American Board of the Histocompatibility & Immunogenetics, the American Board of Medical Laboratory Immunology and the American Board of Bioanalysis. He is also a fellow of the Royal College of Pathologists (London, UK). Dr. Askar is the President of The American Board of Histocompatibility and Immunogenetics (ABHI), President-Elect of The American Society for Histocompatibility and Immunogenetics (ASHI). He is also a Councilor to The Transplantation Society (TTS) representing North America, the Co-Chair of TTS Education Committee and a project leader for the Next Generation Sequencing (NGS) in the 18thInternational HLA and Immunogenetics Workshop that will be held in Amsterdam, Netherlands in 2021. Dr. Askar is a member of the Laboratory Practice Committee of the International Society of Cell and Gene Therapy and a principle Investigator on a number of study protocols through the Center for International Blood and Marrow Transplant Research (CIBMTR).
11:10 - 12:10
|Interactive Workshop — Epitope Matching: Are we ready for prime time?||The role of HLA epitopes in histocompatibility<span uk-icon="video-camera"></span>||Bayshore D|